Streetbeat News

Regulatory

AAPL

Russia's Federal Security Service (FSB) claims to have detected a U.S. National Security Agency (NSA) plot using malware to exploit backdoor vulnerabilities in Apple iPhones. The FSB identified victims involving several thousand Apple phones, including domestic Russian subscribers and foreign diplomats.

Portfolio Pulse from Anusuya Lahiri

June 01, 2023 | 12:15 pm

ESPR

Esperion has submitted supplemental New Drug Applications (sNDAs) to the U.S. FDA for NEXLETOL and NEXLIZET tablets, aiming to expand their indications.

Portfolio Pulse from Benzinga Newsdesk

June 01, 2023 | 12:05 pm

PXMD

PaxMedica has completed its HAT-301 registrational trial for PAX-101, with top line results expected to be released in July 2023.

Portfolio Pulse from Benzinga Newsdesk

June 01, 2023 | 12:04 pm

MTEM

Molecular Templates announced that the FDA has removed the partial clinical hold on its Phase 1 clinical trial for MT-0169, allowing the company to focus on extramedullary myeloma.

Portfolio Pulse from Benzinga Newsdesk

June 01, 2023 | 12:00 pm

PYPL

PayPal has filed a U.S. patent application (#20230169587) for multi-layer artificial intelligence models aimed at progressive predictions during data pipeline management. This technology could enhance PayPal's data processing capabilities and improve its services.

Portfolio Pulse from Charles Gross

June 01, 2023 | 11:45 am

VQS

VIQ Solutions (NASDAQ:VQS) has filed two provisional patent applications with the USPTO for methods related to training and automated selection of domain-specific language models, aiming to improve documentation accuracy and usability for various organizations.

Portfolio Pulse from Charles Gross

June 01, 2023 | 11:39 am

SNSE

Sensei Biotherapeutics announced the first patient dosed in a Phase 1/2 clinical trial of SNS-101, a conditionally active VISTA-blocking antibody, for the treatment of advanced solid tumors. SNS-101 is designed to selectively block the immune checkpoint VISTA in the tumor microenvironment.

Portfolio Pulse from Benzinga Newsdesk

June 01, 2023 | 11:33 am

FSR

Fisker Ocean Extreme has received an EPA Certificate of Conformity and a California Air Resources Board Executive Order, approving it for sale and delivery in the US.

Portfolio Pulse from Charles Gross

June 01, 2023 | 11:11 am

CLSD

Clearside Biomedical has opened enrollment for its ODYSSEY Phase 2b clinical trial of CLS-AX in Wet AMD. The trial is a randomized, double-masked, parallel-group, active-controlled, multi-center study with a duration of 36 weeks.

Portfolio Pulse from Benzinga Newsdesk

June 01, 2023 | 11:11 am

TSLA

Elon Musk concluded his first visit to China in three years, meeting with Foreign Minister Qin Gang, industry and commerce ministers, and visiting Tesla's Shanghai factory. Musk discussed Tesla's expansion and advancement in China during the trip.

Portfolio Pulse from Anan Ashraf

June 01, 2023 | 11:09 am